Ignite Creation Date:
2025-12-24 @ 3:01 PM
Ignite Modification Date:
2025-12-26 @ 5:50 PM
Study NCT ID:
NCT01521559
Status:
COMPLETED
Last Update Posted:
2014-11-13
First Post:
2012-01-26
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study to Assess the Clinical Efficacy and Safety of Intravitreal Aflibercept Injection (IAI;EYLEA®;BAY86-5321) in Patients With Branch Retinal Vein Occlusion (BRVO)
Sponsor:
Regeneron Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-04
Start Date Type:
None
Primary Completion Date:
2013-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-03
Completion Date Type:
ACTUAL
First Submit Date:
2012-01-26
First Submit QC Date:
None
Study First Post Date:
2012-01-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-11-05
Results First Submit QC Date:
None
Results First Post Date:
2014-11-13
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2014-07-14
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2014-11-05
Last Update Post Date:
2014-11-13
Last Update Post Date Type:
ESTIMATED